Showing results (141-150 of 246) with videos related to
Sort By:
Pageof 25
Bioorganic & Medicinal Chemistry|August 27, 2018
An antimycobacterial pleuromutilin analogue effective against dormant bacilliMaddie R Lemieux, Shajila Siricilla, Katsuhiko Mitachi, et al.Journal of Medicinal Chemistry|August 18, 2011
Synthesis and structure-activity relationships of varied ether linker analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5h-imidazo[2,1-b][1,3]oxazine (PA-824)Andrew M Thompson, Hamish S Sutherland, Brian D Palmer, et al.Journal of Medicinal Chemistry|December 14, 2011
Structure-activity relationships for amide-, carbamate-, and urea-linked analogues of the tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)Adrian Blaser, Brian D Palmer, Hamish S Sutherland, et al.ACS Infectious Diseases|June 30, 2022
Optimization of Benzoxazinorifamycins to Minimize hPXR Activation for the Treatment of Tuberculosis and HIV CoinfectionShireen R Ashkar, Walajapet Rajeswaran, Pil H Lee, et al.Journal of Medicinal Chemistry|November 26, 2009
Synthesis and structure-activity studies of biphenyl analogues of the tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)Brian D Palmer, Andrew M Thompson, Hamish S Sutherland, et al.Scientia Pharmaceutica|September 21, 2017
In Vitro Activities of Enantiopure and Racemic 1'-Acetoxychavicol Acetate against Clinical Isolates of Mycobacterium tuberculosisSaradee Warit, Kamolchanok Rukseree, Therdsak Prammananan, et al.Journal of Medicinal Chemistry|December 9, 2009
Synthesis and structure-activity relationships of antitubercular 2-nitroimidazooxazines bearing heterocyclic side chainsHamish S Sutherland, Adrian Blaser, Iveta Kmentova, et al.ACS Chemical Biology|December 3, 2025
Selectivity of the Time-Dependent <i>M. tuberculosis</i> LeuRS Inhibitor Ganfeborole Is Driven by Target VulnerabilityMingqian Wang, YongLe He, Siobhan A Cohen, et al.Bioorganic & Medicinal Chemistry|December 10, 2013
Synthesis of 3-(3-aryl-pyrrolidin-1-yl)-5-aryl-1,2,4-triazines that have antibacterial activity and also inhibit inorganic pyrophosphataseWei Lv, Biplab Banerjee, Katrina L Molland, et al.Tuberculosis (Edinburgh, Scotland)|October 10, 2008
Structure-activity relationships of macrolides against Mycobacterium tuberculosisZhaohai J Zhu, Olga Krasnykh, Dahua Pan, et al.Pageof 25